Eyeworld Daily News

2017 ASCRS Los Angeles Daily Sunday

EyeWorld Today is the official daily of the ASCRS Symposium & Congress. Each issue provides comprehensive coverage editorial coverage of meeting presentations, events, and breaking news

Issue link: https://daily.eyeworld.org/i/820839

Contents of this Issue

Navigation

Page 46 of 112

EW SHOW DAILY 46 Meeting Reporter Sunday, May 7, 2017 by Lauren Lipuma EyeWorld Contributing Writer Catching ocular surface disease upfront is crucial to getting the best surgical outcomes, surgeons say postop infection, higher-order aberrations, and patient dissatisfac- tion, said Kenneth Beckman, MD, Columbus, Ohio. The tear film has the greatest optical power of any surface in the eye because the greatest change in refractive index occurs between air and the tear film. If the tear film becomes irregular, much larger variations in the anterior radius and optical power can occur, which can throw off IOL power calculations, Dr. Beckman said. Sometimes, OSD can cause abnormal topography, which could lead the surgeon to choose a toric IOL when it's not needed, he added. In addition to selecting the wrong IOL, undiagnosed or untreated OSD can lead to positioning a toric IOL on the wrong axis or doing unnec- essary enhancements, Dr. Beckman said. N ot diagnosing and treat- ing ocular surface disease (OSD) before cataract sur- gery can lead to infection, inaccurate preoperative measurements, and postoperative aberrations and patient dissatisfac- tion, said surgeons at Saturday's EyeWorld CME Education sympo- sium, "The Third Refractive Surface: Improving Surgical Outcomes with Advanced Ocular Surface Diagnos- tics and Therapeutics." In this session, physicians shared the reasons why catching and treating OSD upfront is crucial to surgical success and offered pearls of wisdom for diagnosing and treating this complex, multifactorial disease. "As a surgeon, I'm always look- ing for premium outcomes," said Eric Donnenfeld, MD, Rockville Centre, New York. "And you can't do premium surgery without a pre- mium ocular surface." The reality is that most cataract surgery patients have some form of OSD, Dr. Donnenfeld said. Christo- pher Starr, MD, New York, esti- mates that 75% of cataract patients have ocular surface disease, and Dr. Donnenfeld suspects that number is closer to 100% when looking at patients over 70. Correctly diagnosing and treating dry eye before surgery helps surgeons obtain accurate and critical preop measurements and prevents continued on page 48 Dr. Starr estimates that 75% of cataract patients have ocular surface disease.

Articles in this issue

Archives of this issue

view archives of Eyeworld Daily News - 2017 ASCRS Los Angeles Daily Sunday